Published in Neurology on May 16, 2012
Hospitalised hip fracture risk with rosiglitazone and pioglitazone use compared with other glucose-lowering drugs. Diabetologia (2012) 1.08
Disease-specific perception of fracture risk and incident fracture rates: GLOW cohort study. Osteoporos Int (2013) 1.00
Risk of fractures in patients with multiple sclerosis: record-linkage study. BMC Neurol (2012) 0.87
Self-report of one-year fracture incidence and osteoporosis prevalence in a community cohort of canadians with spinal cord injury. Top Spinal Cord Inj Rehabil (2014) 0.81
The association between multiple sclerosis and fracture risk. Int J Clin Exp Med (2014) 0.78
Multiple sclerosis increases fracture risk: a meta-analysis. Biomed Res Int (2015) 0.76
Bone mineral density in patients with multiple sclerosis, hereditary ataxia or hereditary spastic paraplegia after at least 10 years of disease - a case control study. BMC Neurol (2016) 0.75
Risk of fractures in patients with multiple sclerosis: a population-based cohort study. Neurology (2012) 0.75
High dose vitamin D supplementation does not affect biochemical bone markers in multiple sclerosis - a randomized controlled trial. BMC Neurol (2017) 0.75
The risks for falls and fractures in multiple sclerosis. Neurology (2012) 0.75
Balance Right in Multiple Sclerosis (BRiMS): a guided self-management programme to reduce falls and improve quality of life, balance and mobility in people with secondary progressive multiple sclerosis: a protocol for a feasibility randomised controlled trial. Pilot Feasibility Stud (2017) 0.75
FRAX and the assessment of fracture probability in men and women from the UK. Osteoporos Int (2008) 8.75
Multiple sclerosis. Lancet (2002) 7.11
Use of oral corticosteroids and risk of fractures. J Bone Miner Res (2000) 4.75
Antidepressants and the risk of falls among nursing home residents. N Engl J Med (1998) 3.19
Vitamin D and multiple sclerosis. Lancet Neurol (2010) 3.15
Benzodiazepines and the risk of falling leading to femur fractures. Dosage more important than elimination half-life. Arch Intern Med (1995) 2.13
Fracture history and bone loss in patients with MS. Neurology (1998) 1.97
Risk of hip/femur fracture after stroke: a population-based case-control study. Stroke (2009) 1.88
Predicting accidental falls in people with multiple sclerosis -- a longitudinal study. Clin Rehabil (2009) 1.74
Psychotropic medications and risk for falls among community-dwelling frail older people: an observational study. J Gerontol A Biol Sci Med Sci (2005) 1.71
Fracture risk with intermittent high-dose oral glucocorticoid therapy. Arthritis Rheum (2007) 1.63
A cross-sectional study of bone health in multiple sclerosis. Neurology (2009) 1.61
Risks of falls in subjects with multiple sclerosis. Arch Phys Med Rehabil (2002) 1.58
Multiple sclerosis: decreased relapse rate through dietary supplementation with calcium, magnesium and vitamin D. Med Hypotheses (1986) 1.52
Injurious falls among middle aged and older adults with multiple sclerosis. Arch Phys Med Rehabil (2008) 1.49
Risk factors for falling among people aged 45 to 90 years with multiple sclerosis. Arch Phys Med Rehabil (2006) 1.44
Serotonin transporter and receptor expression in osteocytic MLO-Y4 cells. Bone (2006) 1.39
Mechanisms of glucocorticoid action in bone. Ann N Y Acad Sci (2002) 1.39
Risk of bone loss in men with multiple sclerosis. Mult Scler (2004) 1.27
The risk of fracture in patients with multiple sclerosis: the UK general practice research database. J Bone Miner Res (2011) 1.22
The multiple faces of autoimmune-mediated bone loss. Nat Rev Endocrinol (2010) 1.22
Immediate fall of bone formation and transient increase of bone resorption in the course of high-dose, short-term glucocorticoid therapy in young patients with multiple sclerosis. J Clin Endocrinol Metab (2004) 1.21
Anti-epileptic medication and bone health. Osteoporos Int (2006) 1.20
Vitamin D deficiency and reduced bone mineral density in multiple sclerosis: effect of ambulatory status and functional capacity. J Bone Miner Metab (2005) 1.17
Current use of thiazide diuretics and prevention of femur fractures. J Clin Epidemiol (1996) 1.09
Use of anti-depressants and the risk of fracture of the hip or femur. Osteoporos Int (2009) 1.08
Bone status in multiple sclerosis: beyond corticosteroids. Mult Scler (2003) 1.08
Reduced bone mass and fat-free mass in women with multiple sclerosis: effects of ambulatory status and glucocorticoid Use. Calcif Tissue Int (1997) 1.08
Depression, fracture risk, and bone loss: a meta-analysis of cohort studies. Osteoporos Int (2010) 1.08
Multiple sclerosis and lifestyle factors: the Hordaland Health Study. Neurol Sci (2005) 1.07
Trends in HRT and anti-osteoporosis medication prescribing in a European population after the WHI study. Osteoporos Int (2008) 1.06
Osteoporosis in multiple sclerosis. Mult Scler (2010) 1.02
Antipsychotic use and the risk of hip/femur fracture: a population-based case-control study. Osteoporos Int (2009) 1.02
Sporadic corticosteroid pulses and osteoporosis in multiple sclerosis. Arch Neurol (1996) 1.00
Does daily vitamin D 800 IU and calcium 1000 mg supplementation decrease the risk of falling in ambulatory women aged 65-71 years? A 3-year randomized population-based trial (OSTPRE-FPS). Maturitas (2010) 0.97
The Danish Multiple Sclerosis Registry. History, data collection and validity. Dan Med Bull (2001) 0.96
The use of clinical risk factors enhances the performance of BMD in the prediction of hip and osteoporotic fractures in men and women. Osteoporos Int (2007) 6.44
Risk of new vertebral fracture in the year following a fracture. JAMA (2001) 6.17
Epidemiology of fractures in England and Wales. Bone (2001) 5.76
Multicenter evaluation of proposed standardized procedure for antifungal susceptibility testing of filamentous fungi. J Clin Microbiol (1997) 5.64
European guidance for the diagnosis and management of osteoporosis in postmenopausal women. Osteoporos Int (2008) 5.27
Perspective. How many women have osteoporosis? J Bone Miner Res (1992) 4.99
Maternal vitamin D status during pregnancy and childhood bone mass at age 9 years: a longitudinal study. Lancet (2006) 4.95
European guidance for the diagnosis and management of osteoporosis in postmenopausal women. Osteoporos Int (2012) 4.88
Radiographic patterns of osteoarthritis of the knee joint in the community: the importance of the patellofemoral joint. Ann Rheum Dis (1992) 4.79
Use of oral corticosteroids and risk of fractures. J Bone Miner Res (2000) 4.75
EULAR recommendations for the management of knee osteoarthritis: report of a task force of the Standing Committee for International Clinical Studies Including Therapeutic Trials (ESCISIT). Ann Rheum Dis (2000) 4.37
Normal CSF ferritin levels in MS suggest against etiologic role of chronic venous insufficiency. Neurology (2010) 3.98
Bone density screening for osteoporosis. Lancet (1990) 3.87
Defining osteoarthritis of the hip for epidemiologic studies. Am J Epidemiol (1990) 3.77
Excess mortality following hip fracture: a systematic epidemiological review. Osteoporos Int (2009) 3.74
Cohort profile: the Hertfordshire cohort study. Int J Epidemiol (2005) 3.62
A systematic review of hip fracture incidence and probability of fracture worldwide. Osteoporos Int (2012) 3.62
Risk of cancer in patients on insulin glargine and other insulin analogues in comparison with those on human insulin: results from a large population-based follow-up study. Diabetologia (2011) 3.52
Bone densitometry in clinical practice. BMJ (1995) 3.48
The epidemiology of corticosteroid-induced osteoporosis: a meta-analysis. Osteoporos Int (2002) 3.45
Complete genomic sequence and analysis of the prion protein gene region from three mammalian species. Genome Res (1998) 3.44
Markers of bone turnover for the prediction of fracture risk and monitoring of osteoporosis treatment: a need for international reference standards. Osteoporos Int (2010) 3.36
The prevalence of vertebral deformity in european men and women: the European Vertebral Osteoporosis Study. J Bone Miner Res (1996) 3.25
Determinants of disability in osteoarthritis of the knee. Ann Rheum Dis (1993) 3.16
Incidence of vertebral fracture in europe: results from the European Prospective Osteoporosis Study (EPOS). J Bone Miner Res (2002) 3.16
Fluoride in drinking water and risk of hip fracture in the UK: a case-control study. Lancet (2000) 3.16
Knee pain and disability in the community. Br J Rheumatol (1992) 3.15
Pectin esterification is spatially regulated both within cell walls and between developing tissues of root apices. Planta (1990) 3.03
GP job satisfaction in 1987, 1990 and 1998: lessons for the future? Fam Pract (2000) 2.99
Bone density threshold and other predictors of vertebral fracture in patients receiving oral glucocorticoid therapy. Arthritis Rheum (2003) 2.94
Maternal vitamin D status during pregnancy and child outcomes. Eur J Clin Nutr (2007) 2.94
Postwithdrawal rebound increase in T2 lesional activity in natalizumab-treated MS patients. Neurology (2007) 2.88
Results of indirect and mixed treatment comparison of fracture efficacy for osteoporosis treatments: a meta-analysis. Osteoporos Int (2012) 2.81
Effect of annual intramuscular vitamin D on fracture risk in elderly men and women--a population-based, randomized, double-blind, placebo-controlled trial. Rheumatology (Oxford) (2007) 2.81
Guidelines for diagnosis and management of osteoporosis. The European Foundation for Osteoporosis and Bone Disease. Osteoporos Int (1997) 2.80
Guidelines for the diagnosis and management of osteoporosis in postmenopausal women and men from the age of 50 years in the UK. Maturitas (2009) 2.74
Back pain in Britain: comparison of two prevalence surveys at an interval of 10 years. BMJ (2000) 2.73
Interim report and recommendations of the World Health Organization Task-Force for Osteoporosis. Osteoporos Int (1999) 2.70
A global representation of vitamin D status in healthy populations. Arch Osteoporos (2012) 2.69
Osteoarthritis of the hip: an occupational disease in farmers. BMJ (1992) 2.69
Health-related quality of life in postmenopausal women with low BMD with or without prevalent vertebral fractures. J Bone Miner Res (2000) 2.55
Occupational physical activities and osteoarthritis of the knee. Arthritis Rheum (2000) 2.54
Manual handling activities and risk of low back pain in nurses. Occup Environ Med (1995) 2.48
Impact of nutrition on muscle mass, strength, and performance in older adults. Osteoporos Int (2012) 2.48
Use of statins and risk of fractures. JAMA (2001) 2.47
Prospective cohort study of predictors of incident low back pain in nurses. BMJ (1997) 2.46
Interpretation and use of FRAX in clinical practice. Osteoporos Int (2011) 2.43
A UK Consensus Group on management of glucocorticoid-induced osteoporosis: an update. J Intern Med (1998) 2.42
Recommendations for standardization and phenotype definitions in genetic studies of osteoarthritis: the TREAT-OA consortium. Osteoarthritis Cartilage (2010) 2.39
Safety, tolerability, and efficacy of orally administered cannabinoids in MS. Neurology (2002) 2.36
Risks of stroke and mortality associated with suboptimal anticoagulation in atrial fibrillation patients. Thromb Haemost (2011) 2.35
Trends in admissions for hip fracture in England and Wales, 1968-85. BMJ (1990) 2.35
Knee osteoarthritis and obesity. Int J Obes Relat Metab Disord (2001) 2.30
Clinical assessment of the long-term risk of fracture in patients with rheumatoid arthritis. Arthritis Rheum (2006) 2.28
How accurate are diagnoses for rheumatoid arthritis and juvenile idiopathic arthritis in the general practice research database? Arthritis Rheum (2008) 2.27
Vertebral fractures predict subsequent fractures. Osteoporos Int (1999) 2.24
Dietary calcium, physical activity, and risk of hip fracture: a prospective study. BMJ (1989) 2.24
Anti-HERG activity and the risk of drug-induced arrhythmias and sudden death. Eur Heart J (2005) 2.24
A multicentre randomized controlled trial of epidural corticosteroid injections for sciatica: the WEST study. Rheumatology (Oxford) (2005) 2.23
Plasma concentrations of 25-hydroxy-vitamin D and 1,25-dihydroxy-vitamin D are related to the phenotype of Gc (vitamin D-binding protein): a cross-sectional study on 595 early postmenopausal women. Calcif Tissue Int (2005) 2.23
Acetabular dysplasia and hip osteoarthritis in Britain and Japan. Br J Rheumatol (1998) 2.22
Bacterial arthritis in an English health district: a 10 year review. Ann Rheum Dis (1986) 2.21
Quality of life in patients with vertebral fractures: validation of the Quality of Life Questionnaire of the European Foundation for Osteoporosis (QUALEFFO). Working Party for Quality of Life of the European Foundation for Osteoporosis. Osteoporos Int (1999) 2.20
Male circumcision for the prevention of heterosexually acquired HIV infection: a meta-analysis of randomized trials involving 11,050 men. HIV Med (2008) 2.19
Psychoactive substance use and the risk of motor vehicle accidents. Accid Anal Prev (2004) 2.19
Consensus recommendations for MS cortical lesion scoring using double inversion recovery MRI. Neurology (2011) 2.17
Vitamin D and skeletal health in infancy and childhood. Osteoporos Int (2014) 2.16
Oral corticosteroids and fracture risk: relationship to daily and cumulative doses. Rheumatology (Oxford) (2000) 2.13
The changing use of disease-modifying anti-rheumatic drugs in individuals with rheumatoid arthritis from the United Kingdom General Practice Research Database. Rheumatology (Oxford) (2005) 2.11
Physical activity at 36 years: patterns and childhood predictors in a longitudinal study. J Epidemiol Community Health (1992) 2.11
Ibudilast in relapsing-remitting multiple sclerosis: a neuroprotectant? Neurology (2010) 2.03
Heart failure in patients treated with bisphosphonates. J Intern Med (2013) 2.00
Clinical impact of 20% worsening on Timed 25-foot Walk and 9-hole Peg Test in multiple sclerosis. Mult Scler (2006) 1.99
Use of oral corticosteroids in the United Kingdom. QJM (2000) 1.95
Are rates of ageing determined in utero? Age Ageing (1998) 1.95
Will elderly rest home residents wear hip protectors? Age Ageing (1998) 1.95
Muscle strength, activity, housing and the risk of falls in elderly people. Age Ageing (1989) 1.94
Radiographic assessment of osteoarthritis in population studies: whither Kellgren and Lawrence? Osteoarthritis Cartilage (1993) 1.88
Spontaneous MxA mRNA level predicts relapses in patients with recently diagnosed MS. Neurology (2010) 1.88
Studies on the role of the morphological constituents of the microsome fraction from rat liver in protein synthesis. Biochem J (1964) 1.86
Use of cyclical etidronate and prevention of non-vertebral fractures. Br J Rheumatol (1998) 1.85
The Global Longitudinal Study of Osteoporosis in Women (GLOW): rationale and study design. Osteoporos Int (2009) 1.85
Vitamin D status and its adequacy in healthy Danish perimenopausal women: relationships to dietary intake, sun exposure and serum parathyroid hormone. Br J Nutr (2001) 1.84
Subtrochanteric fractures after long-term treatment with bisphosphonates: a European Society on Clinical and Economic Aspects of Osteoporosis and Osteoarthritis, and International Osteoporosis Foundation Working Group Report. Osteoporos Int (2010) 1.83
Physical activity and calcium intake in fracture of the proximal femur in Hong Kong. BMJ (1988) 1.83
Treatment failure in osteoporosis. Osteoporos Int (2012) 1.82
Clinical risk factors, bone density and fall history in the prediction of incident fracture among men and women. Bone (2012) 1.82
Neonatal bone mass: influence of parental birthweight, maternal smoking, body composition, and activity during pregnancy. J Bone Miner Res (2001) 1.82
Characterization of GmENOD40, a gene showing novel patterns of cell-specific expression during soybean nodule development. Plant J (1993) 1.81
Systematic review of the psychological consequences of false-positive screening mammograms. Health Technol Assess (2013) 1.81
Osteoporosis, falls, and age in fracture of the proximal femur. Br Med J (Clin Res Ed) (1987) 1.81
Rectal spirochaetosis in homosexual men: characterisation of the organism and pathophysiology. Genitourin Med (1986) 1.79
Incidence of distal forearm fracture in British men and women. Osteoporos Int (2001) 1.79
Global vitamin D levels in relation to age, gender, skin pigmentation and latitude: an ecologic meta-regression analysis. Osteoporos Int (2008) 1.78
Ki-67 and outcome in clinically localised prostate cancer: analysis of conservatively treated prostate cancer patients from the Trans-Atlantic Prostate Group study. Br J Cancer (2009) 1.77